Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
NCT01926288 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 287
Last updated 2017-12-29
Summary
The purpose of this study is to evaluate the safety and efficacy of Entecavir maleate tablets in Chinese patients with hepatitis B
Conditions
Interventions
- DRUG
-
Entecavir maleate tablets
- DRUG
-
blank Baraclude tablets
- DRUG
-
Blank maleate entecavir tablets
- DRUG
-
Baraclude tablets
Sponsors & Collaborators
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Yu Yan yan, doctor · Department of Infectious Diseases,Peking University First Hospital
-
Shi Guang feng, doctor · Huashan Hospital
-
Xie Qing, doctor · Shanghai Jiaotong University Affiliated Ruijin Hospital
-
Tang Hong, doctor · West China Hospital
-
Zhang Da zhi, doctor · The Second Affiliated Hospital of Chongqing Medical University
-
Mao Qing, doctor · The First Affiliated Hospital Of The Third Mililary Medical University
-
Ning Qin, doctor · Tongji Medical College of Hust Tongji Medical College Huazhong University of Science and Technology
-
Li Jun, doctor · The First Affiliated Hospital with Nanjing Medical University
-
Sheng Ji fang, doctor · Zhejiang University
-
Cheng Xin fang, doctor · Beijing You An Hospital,Capital Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- China
Study Locations
More Related Trials
-
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
NCT01833611 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
NCT04147208 ·Status: COMPLETED ·Phase: PHASE2
-
A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection
NCT05017116 ·Status: COMPLETED ·Phase: PHASE1
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B
NCT02287857 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
NCT03173599 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Dose Response Study in Japan in Chronic Hepatitis B
NCT01022801 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients
NCT03332329 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
NCT05391360 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment
NCT02365402 ·Status: UNKNOWN ·Phase: PHASE4
-
Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
NCT02327676 ·Status: UNKNOWN ·Phase: PHASE4
-
Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis
NCT00663182 ·Status: UNKNOWN ·Phase: PHASE4
-
Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
NCT02327702 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647 ·Status: RECRUITING
-
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy
NCT01037166 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B
NCT02532413 ·Status: UNKNOWN ·Phase: PHASE4
-
Continue Entecavir Rollover From China
NCT00975091 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
NCT01326546 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
NCT06680232 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01026610 ·Status: COMPLETED ·Phase: PHASE2
-
Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients
NCT02588937 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
NCT01829685 ·Status: UNKNOWN ·Phase: PHASE4
-
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b
NCT04195074 ·Status: UNKNOWN ·Phase: NA
-
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection
NCT01020565 ·Status: COMPLETED ·Phase: PHASE2